Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
Berta Rodés(Madrid Health Service), Vincent Soriano(Instituto de Salud Carlos III), Victoria Jiménez(Madrid Health Service), Terri Wrin, Ellen E. Paxinos(Smithsonian Institution), José M. Benito(Hospital Universitario Rey Juan Carlos), Eva Poveda(Madrid Health Service), Manuel Martinez-Padial(Madrid Health Service), Carlos Toro(Madrid Health Service), Sylvina Bassani(Madrid Health Service)
Cited by 115
Related Papers
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
|Proceedings of the National Academy of Sciences|2003|1.2k
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
|Cell Reports|2021|266
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis
|Clinical Infectious Diseases|2021|241
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
|Journal of Viral Hepatitis|2011|234